What one share of Skinvisible holds
Pharmaceuticals Inc., are a pharmaceutical research and development (“R&D”) company that has developed and patented an innovative polymer delivery system, Invisicare® and formulated over forty topical skin products, which we out-license globally.
Skinvisible’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.19 |
| Cash and investments | $0.00 |
| Debt | $0.07 |
| Book value | −$2.00 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $0.13 | −$0.60 | — | — | — | −$0.38 |
| 2011 | $0.09 | −$0.67 | — | — | — | −$0.35 |
| 2012 | $0.12 | −$0.67 | — | — | — | −$0.74 |
| 2013 | $0.03 | −$0.61 | — | — | — | −$1.23 |
| 2014 | $0.02 | −$0.86 | — | — | — | −$1.95 |
| 2015 | $0.08 | −$0.87 | — | — | — | −$2.45 |
| 2016 | $0.05 | −$0.87 | — | — | — | −$2.47 |
| 2017 | $0.24 | −$0.70 | — | — | — | −$2.47 |
| 2019 | $0.01 | −$0.59 | — | — | — | −$0.67 |
| 2020 | $0.03 | −$0.32 | — | — | — | −$0.98 |
| 2021 | $0.15 | −$0.24 | — | — | — | −$1.19 |
| 2022 | $0.06 | −$0.27 | — | — | — | −$1.46 |
| 2023 | $0.00 | −$0.52 | — | — | — | −$1.99 |
| 2024 | $0.00 | −$0.11 | $0.00 | −$0.02 | — | −$1.73 |
| 2025 | $0.00 | −$0.20 | $0.00 | −$0.01 | — | −$1.90 |
Common questions about Skinvisible
How much does one share of Skinvisible earn?
Over the last 12 months, Skinvisible lost $0.19 for each share on $0.00 of sales.
Does Skinvisible pay a dividend?
Skinvisible didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Skinvisible’s book value per share?
Skinvisible’s book value is negative (−$2.00 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Skinvisible have?
Each share of Skinvisible has $0.00 of cash and investments and $0.07 of debt, as of June 30, 2026.
Has Skinvisible bought back shares?
Skinvisible’s share count rose about 200% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.